MALE UROGENITAL DISEASES
Clinical trials for MALE UROGENITAL DISEASES explained in plain language.
Never miss a new study
Get alerted when new MALE UROGENITAL DISEASES trials appear
Sign up with your email to follow new studies for MALE UROGENITAL DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for rare penile cancer
Disease control Recruiting nowThis study tests a combination of chemotherapy (carboplatin and paclitaxel) plus an immunotherapy drug (pembrolizumab) in 27 men with advanced penile cancer that has spread to lymph nodes. The goal is to see if this treatment can completely eliminate the cancer before surgery. Pa…
Matched conditions: MALE UROGENITAL DISEASES
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 17, 2026 04:13 UTC
-
Could a dual immunotherapy spare the bladder in cancer patients?
Disease control Recruiting nowThis study tests whether giving two immunotherapy drugs (nivolumab with or without relatlimab) before surgery can eliminate bladder cancer completely, allowing some patients to avoid bladder removal. About 90 adults with stage II-IIIa bladder cancer will receive the drugs and the…
Matched conditions: MALE UROGENITAL DISEASES
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for kidney cancer: vorolanib under the microscope
Disease control Recruiting nowThis study looks at how well the drug vorolanib works for people with advanced kidney cancer that has spread or cannot be removed by surgery. It is for patients who need a second treatment after the first one stopped working. Researchers will track how long patients live without …
Matched conditions: MALE UROGENITAL DISEASES
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New drug combo trial offers hope for Hard-to-Treat prostate cancer
Disease control Recruiting nowThis study tests a new drug called pocenbrodib, either by itself or combined with other treatments, in people with a type of advanced prostate cancer that no longer responds to hormone therapy. The goal is to find the safest dose and see if it helps shrink tumors or lower PSA lev…
Matched conditions: MALE UROGENITAL DISEASES
Phase: PHASE1, PHASE2 • Sponsor: Pathos AI, Inc. • Aim: Disease control
Last updated May 12, 2026 13:39 UTC